Researchers have been delving deeply into geographic atrophy (GA) to increase the knowledge base of end-stage age-related macular degeneration (AMD). The focus has been on earlier intervention to ...

We spoke with Andrea Govetto, MD, PhD, winner of the inaugural Ramin Tadayoni Award at EURETINA On the opening day of the European Society of Retina Specialists (EURETINA) meeting, Andrea Govetto, MD, ...

4D Molecular Therapeutics has announced data based on the longest interim follow-up from Phase 1/2 PRISM clinical trial and 4FRONT Phase 3 study design. 4D Molecular Therapeutics has announced data ...

Veeral S. Sheth, MD, MBA, FASRS, FACS, discussed the outcome of the Phase 1 HELIOS trial of OTX-TKI at from this year's EURETINA congress being held in Barcelona, Spain, which takes place September 19 ...

In a study, a team of researchers with the OhioHealth Grant Medical Center Family Medicine practice implemented diabetic retinopathy screening using in-clinic retinal photographs and automated ...

The PPQ campaign consisted of the production of 3 successful consecutive commercial-scale drug substance batches required for the validation of Opthea’s manufacturing process. Opthea has completed its ...

EyeBio is developing a pipeline of clinical and preclinical candidates for the prevention and treatment of vision loss associated with retinal vascular leakage.

For years, the retina terrified me. I graduated from optometry school with many ocular pathology courses under my belt and disease-heavy rotations, but I still felt trepidation when examining, ...

Why having a set process for diagnostic imaging is crucial to patient outcomes Ahead of this year’s European Society of Retina Specialists (EURETINA) meeting, we sat down with Ricardo Leitão Guerra, ...

Oral gildeuretinol demonstrated a clinically meaningful reduction in the GA lesion growth rate at 24 months in the SAGA study. Alkeus Pharmaceuticals, Inc. released that the SAGA study of oral ...

Patients with Bothnia Dystrophy, a rare form of retinitis pigmentosa that causes legal blindness by early adulthood, benefited from subretinal administration of AAV8-RLBP1 gene therapy, which was ...

Opthea Limited has made changes to the company’s executive leadership in its finance and commercial areas and has made notable hires in its biometrics, clinical operations, and market access ...